De Velasco, M.A.; Kura, Y.; Ando, N.; Sako, N.; Banno, E.; Fujita, K.; Nozawa, M.; Yoshimura, K.; Sakai, K.; Yoshikawa, K.;
et al. Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer. Cancers 2021, 13, 3975.
https://doi.org/10.3390/cancers13163975
AMA Style
De Velasco MA, Kura Y, Ando N, Sako N, Banno E, Fujita K, Nozawa M, Yoshimura K, Sakai K, Yoshikawa K,
et al. Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer. Cancers. 2021; 13(16):3975.
https://doi.org/10.3390/cancers13163975
Chicago/Turabian Style
De Velasco, Marco A., Yurie Kura, Naomi Ando, Noriko Sako, Eri Banno, Kazutoshi Fujita, Masahiro Nozawa, Kazuhiro Yoshimura, Kazuko Sakai, Kazuhiro Yoshikawa,
and et al. 2021. "Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer" Cancers 13, no. 16: 3975.
https://doi.org/10.3390/cancers13163975
APA Style
De Velasco, M. A., Kura, Y., Ando, N., Sako, N., Banno, E., Fujita, K., Nozawa, M., Yoshimura, K., Sakai, K., Yoshikawa, K., Nishio, K., & Uemura, H.
(2021). Context-Specific Efficacy of Apalutamide Therapy in Preclinical Models of Pten-Deficient Prostate Cancer. Cancers, 13(16), 3975.
https://doi.org/10.3390/cancers13163975